|
1
|
Hattori K, Lee H, Hurn PD, Crain BJ,
Traystman RJ and DeVries AC: Cognitive deficits after focal
cerebral ischemia in mice. Stroke. 31:1939–1944. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bouët V, Freret T, Toutain J, Divoux D,
Boulouard M and Schumann-Bard P: Sensorimotor and cognitive
deficits after transient middle cerebral artery occlusion in the
mouse. Exp Neurol. 203:555–567. 2007.PubMed/NCBI
|
|
3
|
Shioda N, Han F, Morioka M and Fukunaga K:
Bis(1-oxy-2-pyridinethiolato)oxovanadium(IV) enhances neurogenesis
via phosphatidylinositol 3-kinase/Akt and extracellular signal
regulated kinase activation in the hippocampal subgranular zone
after mouse focal cerebral ischemia. Neuroscience. 155:876–887.
2008. View Article : Google Scholar
|
|
4
|
Lee TH, Kato H, Chen ST, Kogure K and
Itoyama Y: Expression of nerve growth factor and trkA after
transient focal cerebral ischemia in rats. Stroke. 29:1687–1697.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Irving EA and Bamford M: Role of mitogen-
and stress-activated kinases in ischemic injury. J Cereb Blood Flow
Metab. 22:631–647. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhao H, Shimohata T, Wang JQ, Sun G,
Schaal DW, Sapolsky RM and Steinberg GK: Akt contributes to
neuroprotection by hypothermia against cerebral ischemia in rats. J
Neurosci. 25:9794–9806. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yin YY, Li WP, Gong HL, Zhu FF, Li WZ and
Wu GC: Protective effect of astragaloside on focal cerebral
ischemia/reperfusion injury in rats. Am J Chin Med. 38:517–527.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yin YY, Li WP, Li WZ, Gong HL, Zhu FF and
Wu GC: Effects of astragalosides on the expression of BDNF, TrkB
and p75NTR mRNA against focal cerebral ischemia-reperfusion injury.
Chinese Pharmacological Bulletin. 25:672–676. 2009.
|
|
9
|
Li W, Li W, Yin Y, Gong H, Wu G and Zhu F:
Protective effects of AST and ASI on memory impairment and its
mechanism in senescent rats treated by GC. Zhongguo Zhong Yao Za
Zhi. 34:199–203. 2009.(In Chinese).
|
|
10
|
Longa EZ, Weinstein PR, Carlson S and
Cummins R: Reversible middle cerebral artery occlusion without
craniectomy in rats. Stroke. 20:84–91. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bederson JB, Pitts LH, Tsuji M, Nishimura
MC, Davis RL and Bartkowski H: Rat middle cerebral artery
occlusion: evaluation of the model and development of a neurologic
examination. Stroke. 17:472–476. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wiard RP, Dickerson MC, Beek O, Norton R
and Cooper BR: Neuroprotective properties of the novel
antiepileptic lamotrigine in a gerbil model of global cerebral
ischemia. Stroke. 26:466–472. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li WZ, Li WP, Zhang W, Yin YY, Sun XX,
Zhou SS, Xu XQ and Tao CR: Protective effect of extract of
Astragalus on learning and memory impairments and neurons’
apoptosis induced by glucocorticoids in 12-month-old male mice.
Anat Rec (Hoboken). 294:1003–1014. 2011.PubMed/NCBI
|
|
14
|
Kim SJ, Yoo KY, Jeong CW, Kim WM, Lee HK,
Bae HB, Kwak SH, Li M and Lee J: Urinary trypsin inhibitors afford
cardioprotective effects through activation of PI3K-Akt and ERK
signal transduction and inhibition of p38 MAPK and JNK. Cardiology.
114:264–270. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang PR, Wang JS, Zhang C, Song XF, Tian N
and Kong LY: Huang-Lian-Jie-Du-Decotion induced protective
autophagy against the injury of cerebral ischemia/reperfusion via
MAPK-mTOR signaling pathway. J Ethnopharmacol. 149:270–280. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhang F, Wang S, Signore AP and Chen J:
Neuroprotective effects of leptin against ischemic injury induced
by oxygen-glucose deprivation and transient cerebral ischemia.
Stroke. 38:2329–2336. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kilic E, Kilic U, Soliz J, Bassetti CL,
Gassmann M and Hermann DM: Brain-derived erythropoietin protects
from focal cerebral ischemia by dual activation of ERK-1/-2 and Akt
pathways. FASEB J. 19:2026–2028. 2005.PubMed/NCBI
|
|
18
|
Lange-Asschenfeldt C, Raval AP, Dave KR,
Mochly-Rosen D, Sick TJ and Pérez-Pinzón MA: Epsilon protein kinase
C mediated ischemic tolerance requires activation of the
extracellular regulated kinase pathway in the organotypic
hippocampal slice. J Cereb Blood Flow Metab. 24:636–645. 2004.
View Article : Google Scholar
|
|
19
|
Tournier C, Hess P, Yang DD, Xu J, Turner
TK, Nimnual A, Bar-Sagi D, Jones SN, Flavell RA and Davis RJ:
Requirement of JNK for stress-induced activation of the cytochrome
c-mediated death pathway. Science. 288:870–874. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lei K, Nimnual A, Zong WX, Kennedy NJ,
Flavell RA, Thompson CB, Bar-Sagi D and Davis RJ: The Bax subfamily
of Bcl2-related proteins is essential for apoptotic signal
transduction by c-Jun NH(2)-terminal kinase. Mol Cell Biol.
22:4929–4942. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Okuno S, Saito A, Hayashi T and Chan PH:
The c-Jun N-terminal protein kinase signaling pathway mediates Bax
activation and subsequent neuronal apoptosis through interaction
with Bim after transient focal cerebral ischemia. J Neurosci.
24:7879–7887. 2004. View Article : Google Scholar
|
